Current research projects include: Discovery of the novel SUMOylation inhibitor as anti-influenza virus agents; The impact of Native American plants as therapeutic supplements on the prevention and treatment of hypertension, hyperlipidemia and chronic inflammatory diseases; Immunological consequences of transcription factor interactions, combined genetic and epigenetic mechanisms on the risk for developing human immune system disease; Effects of maternal supplements on fetal developmental programing and offspring health outcome
▪ Applied NIH R15 grant 2018 as PI, The novel SUMOylation inhibitor as anti-influenza virus agents
▪ Applied NIH R15 grant 2018 as PI, Maternal Immunology and Offspring Allergy
▪ Applied BMRP at CCFA grant as PI, Native American plants as therapeutic supplements for the treatment of IBD (inflammatory bowel disease)
▪ Research collaborative institutions: UC Riverside Bourns College of Engineering, Harvard University Mucosal Immunology Laboratory, University of South California School of Pharmacy, University of Illinois at Urbana-Champaign Division of Human Nutrition, Boston University School of Medicine, Zhejiang University College of Animal Sciences
